TrialCancer research and treatment2017

Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results.

Yeon Hee Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.